Filter
1022
Text search:
second-line
Featured
Recommendations
129
New Publications
320
Language
Document type
No document type
704
Guidelines
128
Studies & Reports
94
Manuals
40
Strategic & Response Plan
19
Fact sheets
16
Training Material
12
Situation Updates
5
Infographics
4
Countries / Regions
India
83
Western and Central Europe
41
Eastern Europe
30
Ethiopia
25
Kenya
25
Tanzania
24
Uganda
23
South Africa
23
Nepal
22
Malawi
18
Namibia
16
Global
16
Rwanda
14
Latin America and the Carribbean
14
Nigeria
12
Zambia
12
Myanmar / Burma
11
Ukraine
10
Cambodia
9
Bangladesh
9
Asia
9
Africa
9
Mozambique
8
Liberia
7
Philippines
7
Sierra Leone
6
Indonesia
6
Zimbabwe
5
South–East Asia Region
5
Russia
5
Senegal
4
Cameroon
4
Ghana
4
Pakistan
4
Botswana
4
Lesotho
4
Albania
4
Eswatini/ Swaziland
3
Tajikistan
3
Burkina Faso
2
Congo, Democratic Republic of
2
Haiti
2
Somalia
2
South Sudan
2
Thailand
2
Argentina
2
Brazil
2
Colombia
2
Bolivia
2
Yemen
2
Armenia
2
Georgia
2
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Gambia
1
China
1
Sudan
1
Peru
1
North Macedonia
1
Madagascar
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
Venezuela
1
Laos
1
Timor Leste/ East Timor
1
Vietnam
1
North America
1
Denmark
1
Authors & Publishers
Publication Years
Category
Countries
389
Clinical Guidelines
141
Women & Child Health
42
Public Health
33
Key Resources
16
Capacity Building
13
Pharmacy & Technologies
11
Toolboxes
TB
277
HIV
182
AMR
54
Mental Health
27
Pharmacy
23
Malaria
20
NTDs
15
COVID-19
11
Caregiver
11
Polio
10
NCDs
10
Refugee
8
Disability
5
Ebola & Marburg
5
Conflict
5
Planetary Health
5
Cholera
4
Rapid Response
4
Global Health Education
3
Health Financing Toolbox
3
Natural Hazards
2
2.0 Rapid Response
2
Zika
1
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in
...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed
...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as
...
WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)? ...
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)? ...
This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype
...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec
...
This book provides significantly expanded content and experience in relation to a broader stewardship context- for example, stewardship in specific populations, different countries as well as the role of different professions in stewardship to political and media engagement. We hope this book has so
...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para
...
HIV & AIDS Treatment in Practice
Issue 203
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
The Polio Transition1
Monitoring and Evaluation (M&E) Framework was designed to monitor progress towards achieving the strategic and operational outcomes of the post-2023 Strategic Action Plan on Polio Transition (2018– 2023), as outlined in the Global Vision to use polio investments to build st
...
